Clinical Oncology Development Webinar Today

The regulatory process can be confusing and difficult, especially for those who work in clinical drug development. Today, the FierceBiotech team brings you "Oncology Trials: Navigating the Regulatory Landscape." Hosted by our Editor-in-Chief John Carroll, this webinar will offer insights on best practices for managing the clinical drug development process and gaining approval. Panelists inlcude Scott Cormack, President and CEO of OncoGenex Technologies; Taylor Burtis, Vice President of Regulatory, Quality and Compliance, Tokai Pharmaceuticals; and Christoph Zanke, Global Strategic Head Oncology, AAIPharma.

If you're in clinical operations, this is a must-attend event. The webinar begins at 2p.m. EST. Don't miss it. Click here to sign up.  - Calisha

Suggested Articles

Mylan and Pfizer's Upjohn have a name for their pending merger: Viatris. Heard that before? So has Mylan, which owns a subsidiary with the same name.

Intercept presented a data analysis that found treatment with Ocaliva led to "early and consistent improvements" in a range of noninvasive tests.

Days before Amarin faces a pivotal FDA vote on its Vascepa expansion, advisors are set to scrutinize the placebo used in its pivotal outcomes trial.